Loading...

Kintor Pharmaceutical Limited

KNTPF•PNK
Healthcare
Biotechnology
$0.37
$0.00(0.00%)
U.S. Market opens in 3h 21m

Kintor Pharmaceutical Limited (KNTPF) Stock Overview

Explore Kintor Pharmaceutical Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap172.3M
P/E Ratio-9.18
EPS (TTM)$-0.06
ROE-0.63%
Fundamental Analysis

AI Price Forecasts

1 Month$0.43
3 Months$0.31
1 Year Target$0.41

KNTPF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Kintor Pharmaceutical Limited (KNTPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.72, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.41.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -9.18 and a market capitalization of 172.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
0.09%
1-Month Change
-15.08%
3-Month Change
5.21%
6-Month Change
36.70%
Year-to-Date (YTD) Change
70.12%
1-Year Change
107.13%
3-Year Change
-49.65%
5-Year Change
-90.30%
All-Time (Max) Change
-70.18%

Contact Information

https://www.kintor.com.cn
86 51 2626 39909
No. 20 Songbei Road, Suzhou, NaN, 215123

Company Facts

168 Employees
IPO DateDec 11, 2020
CountryCN
Actively Trading

Frequently Asked Questions